co.don AG Xetra

CNWK

DE000A1K0227

Pharmaceuticals

End-of-day quote Xetra Other stock markets 06:00:00 2022-09-29 pm EDT			5-day change	1st Jan Change
0.245 ^EUR	-28.99%		-25.76%	-.--%

CO.DON AG Appoints Achim Simons to Executive Board

December 17, 2020 at 06:47 am EST

The Supervisory Board of CO.DON AG has appointed Dr. Achim Simons to the Executive Board of CO.DON AG with effect from 1 January 2021. Dr. Simons was previously a surgeon.

Co.don AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal particular cartilage defects, lumbar disc herniation, non-union fractures and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, particularly in the knee area; co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The Company is active domestically and in other European countries.

Sector

Pharmaceuticals

Calendar

2024-04-25 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
CSL LIMITED	-4.66%	87.53B
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	40.42B
BIOGEN INC.	-19.39%	29.48B
UCB	+57.86%	25.43B
INCYTE CORPORATION	-17.66%	11.49B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.00%	11.3B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.14%	11.1B
SWEDISH ORPHAN BIOVITRUM AB	+5.24%	8.75B
INNOVENT BIOLOGICS, INC.	-8.42%	7.99B

Biopharmaceuticals

co.don AG Xetra

Equities

CNWK

DE000A1K0227

Pharmaceuticals

CO.DON AG Appoints Achim Simons to Executive Board

Latest news about co.don AG

Chart co.don AG

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Biopharmaceuticals